Kineta to Extend Research Collaboration with Genentech to Develop a Novel Non-Opioid
Collaboration to advance a first-in-class α9/α10 nAchR antagonist for the treatment of chronic pain into Phase 1 clinical trials Seattle, WA -- (October 7, 2020) Kineta Chronic Pain, LLC, a subsidi ...